Blue Fin Capital’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Sell
4,235
-559
-12% -$244K 0.24% 63
2026
Q1
$2.21M Buy
4,794
+25
+0.5% +$12.6K 0.36% 51
2025
Q4
$2.7M Sell
4,769
-143
-3% -$76.1K 0.42% 44
2025
Q3
$2.2M Sell
4,912
-435
-8% -$209K 0.35% 51
2025
Q2
$2.91M Buy
5,347
+332
+7% +$174K 0.49% 42
2025
Q1
$2.48M Buy
5,015
+3,418
+214% +$1.89M 0.48% 41
2024
Q4
$834K Buy
1,597
+191
+14% +$99.5K 0.15% 83
2024
Q3
$691K Buy
1,406
+60
+4% +$27.9K 0.13% 88
2024
Q2
$599K Buy
1,346
+462
+52% +$184K 0.12% 88
2024
Q1
$353K Buy
884
+20
+2% +$7.56K 0.08% 113
2023
Q4
$291K Buy
864
+64
+8% +$19.1K 0.07% 120
2023
Q3
$234K Buy
800
+105
+15% +$32.8K 0.07% 124
2023
Q2
$238K Sell
695
-4
-0.6% -$1.21K 0.07% 125
2023
Q1
$212K Buy
+699
New +$172K 0.07% 129
2022
Q2
Sell
-770
Closed -$232K 136
2022
Q1
$232K Buy
770
+71
+10% +$20.7K 0.07% 121
2021
Q4
$251K Buy
+699
New +$240K 0.07% 122

Other funds holding ISRG

Blue Fin Capital's ISRG Position: Q2 2026 in Review

Blue Fin Capital reduced its Intuitive Surgical (ISRG) stake by 12% in Q2 2026, selling an estimated $244K and leaving 4,235 shares worth $1.68M. The position accounts for 0.24% of the portfolio, ranked #63.

Blue Fin Capital first reported a position in ISRG in Q4 2021 and has held it in 16 quarters since. The position peaked at $2.91M in Q2 2025. 1,081 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Blue Fin Capital held 4,235 shares of Intuitive Surgical worth $1.68M as of Q2 2026.
  • Blue Fin Capital sold 559 Intuitive Surgical shares in Q2 2026, an estimated $244K.
  • Intuitive Surgical made up 0.24% of Blue Fin Capital's portfolio in Q2 2026, its #63 holding.
  • Blue Fin Capital first reported a position in Intuitive Surgical in Q4 2021 and has held it in 16 quarters since.
  • Blue Fin Capital's Intuitive Surgical position peaked at $2.91M in Q2 2025.
  • 1,081 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Blue Fin Capital's 13F filing for Q2 2026, filed 4 Aug 2026.